Optimizing Endoscopy Procedure Documentation Improves Guideline-Adherent Care in Upper Gastrointestinal Bleeding.

Authors:
Yen T; Jones B; Espinoza JM; Singh S; Pell J and 4 more

Journal:
Dig Dis Sci

Publication Year: 2023

DOI:
10.1007/s10620-023-07823-6

PMCID:
PMC9841959

PMID:
36645637

Journal Information

Full Title: Dig Dis Sci

Abbreviation: Dig Dis Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations DisclosuresTY: Supported by University of Colorado Hospital/School of Medicine Clinical Effective and Patient Safety Small Grants Program for Residents and Fellows (CEPS-RF). SS: Research support from the National Palliative Care Research Center. JE, JP, BJ, AD: None. SW: Consultant Boston Scientific, Medtronic, Cernostics, Interpace, Exact Sciences. Research Support from Lucid, CDx, Ambu, Supported by NIH/NIDDK U34DK124174, U01DK129191. FIS: Consultant to Janssen, Merck, and Takeda Pharmaceuticals. He has received research funding from Takeda, Janssen, and the Crohn’s and Colitis Foundation. SGP: Olympus America (research support), ERBE USA (honorarium), Research support from the American Cancer Society. Writing Assistance: None. Guarantor of article: Timothy Yen MD. Ethical approvalThe study was exempt as “Not-Human Subject Research” after review by the Colorado Multiple Institutions Review Board. Disclosures TY: Supported by University of Colorado Hospital/School of Medicine Clinical Effective and Patient Safety Small Grants Program for Residents and Fellows (CEPS-RF). SS: Research support from the National Palliative Care Research Center. JE, JP, BJ, AD: None. SW: Consultant Boston Scientific, Medtronic, Cernostics, Interpace, Exact Sciences. Research Support from Lucid, CDx, Ambu, Supported by NIH/NIDDK U34DK124174, U01DK129191. FIS: Consultant to Janssen, Merck, and Takeda Pharmaceuticals. He has received research funding from Takeda, Janssen, and the Crohn’s and Colitis Foundation. SGP: Olympus America (research support), ERBE USA (honorarium), Research support from the American Cancer Society. Writing Assistance: None. Guarantor of article: Timothy Yen MD."

Evidence found in paper:

"Funding Open access funding provided by SCELC, Statewide California Electronic Library Consortium. University of Colorado Hospital/School of Medicine Clinical Effective and Patient Safety Small Grants Program for Residents and Fellows (CEPS-RF); NIH/NCRR Colorado CTSI Grant Number UL1 RR025780 (Redcap) (Grant No. 63503482)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025